Literature DB >> 7199472

Phase I clinical trial with ametantrone (NSC-287513).

M Piccart, M Rozencweig, R Abele, E Cumps, P Dodion, D Dupont, D Kisner, Y Kenis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7199472     DOI： 10.1016/0014-2964(81)90233-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  3 in total

1.  A phase I trial of ametantrone acetate (NSC-287513).

Authors:  R A Gams; F Ostroy; J F Bender; A J Grillo-López
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Pharmacokinetics of ametantrone acetate (NSC-287513).

Authors:  J G Kuhn; C E Balmer; T M Ludden; D M Loesch; D D Von Hoff; J F Bender; A J Grillo-Lopez
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives.

Authors:  D Bron; P Dodion; M Rozencweig; A Delforge; M A Mattelaer; Y Kenis; P Stryckmans
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.